Normal view MARC view ISBD view

Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling. [electronic resource]

By:

Clarke, Robert

Contributor(s):

Producer: 20031121Description: 7316-39 p. digitalISSN:

0950-9232

Subject(s):

Online resources:

Available from publisher's website

In: Oncogene vol. 22

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.; Review

There are no comments on this title.

to post a comment.

Back to results

1 Re: Editorial comment on Role of marker lesion when applying intravesical instillations of IL-2 for non-muscle-invasive bladder cancer comparison of the therapeutic effects in two pilot studies: D. P. Wood J Urol 2014; 191: 348.
by Den Otter, Willem
2 Local interleukin 2 therapy is most effective against cancer when injected intratumourally.
by Jacobs, John J L
3 Testing therapeutic potency of anticancer drugs in animal studies: a commentary.
by Den Otter, Willem
4 Mechanisms of macrophage cytotoxicity in IL-2 and IL-12 mediated tumour regression.
by Masztalerz, Agnieszka
5 Therapeutic response of untreatable hepatocellular carcinoma after application of the immune modulators IL-2, BCG and melatonin.
by Tomov, Bojidar
6 Local interleukin-2 and interleukin-12 therapy of bovine ocular squamous cell carcinomas.
by Stewart, Rachel J E
7 An infant with Down syndrome and retinoblastoma. A possible non-fortuitous association.
by Moll, Annette C
8 Further development of local IL-2 therapy of cancer: multiple versus single IL-2 treatment of transplanted murine colon carcinoma.
by Kusnierczyk, Halina
9 A method to estimate cell cycle time and growth fraction using bromodeoxyuridine-flow cytometry data from a single sample.
by Eidukevicius, Rimantas
10 Therapeutic efficacy of IL-2-loaded hydrogels in a mouse tumor model.
by De Groot, Cornelis J
11 Predictive value of CD8highCD57+ lymphocyte subset in interferon therapy of patients with renal cell carcinoma.
by Characiejus, Dainius
12 The mechanism of regression of solid SL2 lymphosarcoma after local IL-2 therapy.
by Baselmans, Anton H C
13 Therapeutic effect of a single peritumoural dose of IL-2 on transplanted murine breast cancer.
by Moiseeva, Ekaterina V
14 Prediction of response in cancer immunotherapy.
by Characiejus, Dainius
15 Inefficacy of therapeutic cancer vaccines and proposed improvements. Casus of prostate cancer.
by Jacobs, John J L
16 Changes in cytokine profile during local IL-2 therapy in cancer patients.
by Tomova, Radosveta
17 Treatment of transmissible venereal tumors in dogs with intratumoral interleukin-2 (IL-2). A pilot study.
by Den Otter, Willem
18 Locoregional IL-2 low dose applications for gastrointestinal tumors.
by Krastev, Zachary
19 The Amiens Strategy: small phase III trials for clinically relevant progress in the war against cancer.
by Jacobs, John J L
20 Treatment of stage III-IV nasopharyngeal carcinomas by external beam irradiation and local low doses of IL-2.
by Jacobs, John J L